Earnings Season in Full Swing, Russell Cutoff Hits Today

US: SanDisk, Intel, and the Semiconductor Reckoning

Intel crashed 23% overnight after its earnings miss. The move sharpened an already crowded short picture across semiconductors. SanDisk reports tonight after a 492% year-to-date run. Options expiries cluster around October 30 and November 6, making today a high-pressure session for market makers. Availability of borrow is above 4,000% of short interest, so this is a call-buyer's market, not a short story.

GE HealthCare is outpacing peers heading into its print, with analysts raising targets ahead of results. That contrasts sharply with Boston Scientific, where three separate analyst calls landed this morning: Jefferies cut from Buy to Hold and slashed its target from $60 to $46, while Canaccord pulled its target to $48. The consensus average target fell to $52.00 from $57.34.

Apple reports Monday, November 2. At a $5 trillion market cap it is the single most-watched print of the week.

Europe: Recordati Deal and MSCI Deletion Risk

CVC Capital Partners has an agreed tender offer for Italian pharma firm Recordati, with an 88% completion probability and a window running to December 15. If the deal closes, ORTEX's Index Rebalance Radar forecasts a 65% chance of a FTSE MIB deletion, forcing an estimated $218 million of selling across roughly 11 days of normal volume. The announcement would likely follow on November 6.

Xero sits on the thinnest edge of the MSCI World November review. It can fall just 2.3% before breaching its exit threshold. A deletion would force $524 million of selling. The announcement falls on November 11.

Russell 2000: Today Is the Day

Today's close sets the Russell 2000 December rebalance. Among 97 names still in play, ORTEX forecasts roughly 45 additions and 14 deletions. VSAT deletion odds jumped from 47% to 80% overnight. It sits 8.1% below the exit line, with a potential $1.3 billion forced sale equal to 8.4 days of volume. Twist Bioscience moved the same way, from 55% to 80%. UMBF sits on both sides of the Russell boundary: a 55% chance of moving up to the Russell 1000 and a simultaneous 55% deletion risk from the Russell 2000. The announcement falls on November 13.

Alt Data Signal

Southern Company produced the sharpest operational reading of the week. Its nuclear reactor output fell 10 standard deviations below its own history on October 28, per NRC reactor status data. Short interest sits at just 2.6% of free float, so this is an operational flag to watch rather than a short-side story.